Disc Medicine (IRON) Change in Acquisitions & Divestments (2024 - 2026)
Disc Medicine's (IRON) quarterly Change in Acquisitions & Divestments came in at $152.1 million in Q1 2026, up 101.5% year-on-year from $75.5 million in Q1 2025, and up 12.31% on a QoQ basis from $135.4 million in Q4 2025.
Disc Medicine (IRON) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Disc Medicine (IRON) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $152.1 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 101.5% year-over-year to $152.1 million in Q1 2026; TTM through Mar 2026 was $532.8 million, a 212.93% increase from a year earlier, with the FY2025 full-year figure at $456.2 million, up 381.24% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $152.1 million, up from $135.4 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for IRON reached as high as $152.1 million in Q1 2026 and fell as low as $23.0 million in Q3 2024.
- Historically, Change in Acquisitions & Divestments has averaged $100.4 million across 3 years, with a median of $110.4 million in 2025.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 486.96% in 2025 and fell as far as 88.58% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $71.8 million in 2024, then surged by 88.58% to $135.4 million in 2025, then climbed by 12.31% to $152.1 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $152.1 million in Q1 2026, $135.4 million in Q4 2025, and $135.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Disc Medicine | 2.89 Bn | 2.89 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 152.07 Mn |
| Mar 31, 2026 | 152.07 Mn |
| Dec 31, 2025 | 135.40 Mn |
| Dec 31, 2025 | 135.40 Mn |
| Sep 30, 2025 | 135.00 Mn |
| Sep 30, 2025 | 135.00 Mn |
| Jun 30, 2025 | 110.35 Mn |
| Jun 30, 2025 | 110.35 Mn |
| Mar 31, 2025 | 75.47 Mn |
| Mar 31, 2025 | 75.47 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Sep 30, 2024 | 23.00 Mn |